Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб, Пульмаген Терапеутикс (Синерджи) ЛимитедfiledCriticalАстразенека Аб
Priority to UAA201013072ApriorityCriticalpatent/UA99521C2/en
Publication of UA99521C2publicationCriticalpatent/UA99521C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
The invention provides named compounds of formula (I), wherein R4 is a N-substituted quinuclidine (1) pharmaceutical compositions containing them and a process for preparing the pharmaceutical compositions. Their use in therapy for the treatment of conditions mediated by M3 muscarinic receptors, such as clironic obstructive pulmonary disease is also disclosed.(I)
UAA201013072A2008-05-132008-05-13Quinuclidine derivatives as m3 muscarinic receptor antagonists
UA99521C2
(en)